amantadine has been researched along with digitoxigenin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebert, N; Hertlein, H; Kreis, W; Müller-Uri, F; Nolte, E; Slany, R; Sobel, A; Taubert, H; Wach, S; Wullich, B | 1 |
1 other study(ies) available for amantadine and digitoxigenin
Article | Year |
---|---|
The New Semisynthetic Cardenolide Analog 3β-[2-(1-Amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) Efficiently Suppresses Cell Growth in Human Leukemia and Urological Tumor Cell Lines.
Topics: Amantadine; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Digitoxigenin; Digitoxin; Humans; Leukemia; Male; Prostatic Neoplasms; Urologic Neoplasms | 2015 |